Kwang-Hoon Chun Selected Research

KD025

5/2020	Identification of novel functions of the ROCK2-specific inhibitor KD025 by bioinformatics analysis.
3/2020	Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and its Pharmacokinetic Application.
1/2018	Anti-adipogenic effects of KD025 (SLx-2119), a ROCK2-specific inhibitor, in 3T3-L1 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kwang-Hoon Chun Research Topics

Disease

7	Neoplasms (Cancer) 09/2015 - 09/2004
3	Inflammation (Inflammations) 01/2021 - 01/2013
2	Insulin Resistance 01/2013 - 03/2011
2	Adenocarcinoma 09/2007 - 07/2007
2	Hypoxia (Hypoxemia) 09/2007 - 02/2006
1	Systemic Scleroderma (Systemic Sclerosis) 03/2020
1	Idiopathic Pulmonary Fibrosis 03/2020
1	Bronchiolitis Obliterans Syndrome 03/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Leukemia 03/2019
1	Melanoma (Melanoma, Malignant) 05/2018
1	Obesity 01/2018
1	Aneuploidy (Aneuploid) 09/2015
1	Experimental Melanoma 08/2015
1	Macular Degeneration (Age-Related Maculopathy) 02/2015
1	Brain Ischemia (Cerebral Ischemia) 01/2015
1	Osteoporosis 01/2015
1	Glioma (Gliomas) 01/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2015
1	Brain Infarction 01/2015
1	Neuroinflammatory Diseases 01/2015
1	Diabetes Mellitus 01/2014
1	Hyperglycemia 01/2014
1	Hypersensitivity (Allergy) 04/2012
1	Type 2 Diabetes Mellitus (MODY) 03/2011
1	Carcinogenesis 09/2007
1	Fibrosarcoma 08/2007
1	Neoplasm Metastasis (Metastasis) 10/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2005
1	Hepatocellular Carcinoma (Hepatoma) 12/2005

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2019 - 02/2006
3	KD025IBA 05/2020 - 01/2018
3	Insulin (Novolin)FDA Link 01/2014 - 03/2011
2	Protein Kinase CIBA 01/2021 - 08/2007
2	Protein Isoforms (Isoforms)IBA 01/2021 - 02/2015
2	Lysine (L-Lysine)FDA Link 03/2019 - 02/2006
2	Sirtuin 1IBA 09/2015 - 01/2015
2	Caspase 3 (Caspase-3)IBA 08/2007 - 12/2005
2	Phosphotransferases (Kinase)IBA 07/2006 - 09/2004
1	CalciumIBA 01/2021
1	DiglyceridesIBA 01/2021
1	Pharmaceutical PreparationsIBA 03/2020
1	Protein Kinases (Protein Kinase)IBA 03/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020
1	Histones (Histone)IBA 03/2019
1	MethyltransferasesIBA 03/2019
1	Melanins (Melanin)IBA 05/2018
1	Conditioned Culture MediaIBA 08/2015
1	6-paradolIBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Neuroprotective AgentsIBA 01/2015
1	shogaolIBA 01/2015
1	Therapeutic UsesIBA 01/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2014
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2012
1	Threonine (L-Threonine)FDA Link 03/2011
1	Serine (L-Serine)FDA Link 03/2011
1	AcetyltransferasesIBA 06/2010
1	Biological ProductsIBA 06/2010
1	Oxygen (Dioxygen)IBA 09/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007
1	Protein Kinase C-deltaIBA 09/2007
1	Cyclin D1IBA 08/2007
1	A Kinase Anchor ProteinsIBA 08/2007
1	Etoposide (VP 16)FDA LinkGeneric 07/2007
1	Cyclin AIBA 07/2007
1	histone H1 kinaseIBA 07/2007
1	ChromatinIBA 07/2006
1	Cytochromes c (Cytochrome c)IBA 12/2005
1	Peptides (Polypeptides)IBA 09/2004
1	CyclinsIBA 09/2004

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2013
1	Glycemic Control 01/2020
1	Oral Administration 01/2014